Stem Cell Cryopreservation Market Growth Drivers and Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Stem Cell Cryopreservation Market Expected To Reach Based On Its 2026 Value?

The stem cell cryopreservation market has experienced rapid expansion recently. Projections indicate its size will increase from $4.17 billion in 2025 to $4.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.8% during this period. Factors contributing to its historical development include the wider reach of stem cell banking initiatives, the growing application of cryopreservation in research settings, an increase in IVF and fertility treatments, the escalating need for prolonged cell storage, and advancements in cryogenic storage technologies.

The stem cell cryopreservation market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $10.17 billion in 2030, growing at a compound annual growth rate (CAGR) of 19.5%. This growth during the forecast period is attributable to the increasing adoption of regenerative medicine therapies, growing investments in biobanking infrastructure, a rising demand for personalized medicine storage solutions, the expansion of clinical cell therapy pipelines, and an increasing focus on standardized storage protocols. Key trends for the forecast period include an increasing demand for long-term stem cell storage, the rising use of advanced cryoprotectants, the growing adoption of automated cryopreservation systems, the expansion of stem cell banking services, and an enhanced focus on cell viability preservation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30405&type=smp

What Factors Are Contributing To The Growth Of The Stem Cell Cryopreservation Market?

The rising occurrence of degenerative diseases is anticipated to drive the expansion of the stem cell cryopreservation market moving ahead. These medical conditions involve the progressive deterioration of the structure or function of tissues or organs over time, often leading to a loss of normal capabilities. The heightened incidence of degenerative diseases is attributed to the growing aging population, as older individuals are more susceptible to the cellular and tissue degradation that results in such ailments. Stem cell cryopreservation facilitates the long-term preservation of viable stem cells, providing a dependable resource for regenerative therapies that assist in repairing and replacing damaged tissues in degenerative diseases. For instance, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit voluntary health organization, approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, and this number is projected to rise to 13.8 million by 2060. Consequently, the expanding prevalence of degenerative diseases is fueling the growth of the stem cell cryopreservation market.

What Are The Different Segment Types In The Stem Cell Cryopreservation Market Segment Breakdown?

The stem cell cryopreservation market covered in this report is segmented –

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell

2) By Application: Cell Freezing Media, Equipment And Consumables

3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics

Subsegments:

1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells

2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell

3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

What Trends Are Shaping The Future Of The Stem Cell Cryopreservation Market?

Companies operating in the stem cell cryopreservation market are concentrating on creating novel solutions, such as enhanced cryopreservation media and automation-friendly freezing systems. These efforts aim to boost post-thaw cell viability and accelerate the progress of stem cell therapy. Advanced cryopreservation media are specifically designed formulations that shield stem cells during freezing and thawing to maintain their viability and function, while automation-friendly freezing systems represent equipment or methods engineered for scalable, reproducible, and hands-free cell freezing in large-scale manufacturing. For example, in April 2024, Pluristyx, Inc., a US-based biotechnology company, introduced PluriFreeze, its exclusive cryopreservation medium. This sophisticated solution is engineered to improve the freezing and thawing of pluripotent stem cells and other delicate cell types, ensuring superior post-thaw viability and functional integrity. Characterized by an entirely synthetic, animal-origin-free composition with low viscosity, PluriFreeze is ideally suited for automated and large-scale cell production. It is further supported by the DMSO-free PluriPrep wash solution, which allows for extended processing times. Made from Generally Recognized as Safe (GRAS) components, the medium delivers consistent, reliable, and secure cryopreservation for both research and clinical uses. By integrating smoothly with platforms such as PluriBank, this launch enhances the stem cell cryopreservation workflow, providing efficient and scalable solutions from laboratory research to clinical application.

Who Are The Well-Known Companies In The Stem Cell Cryopreservation Market?

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Get The Full Stem Cell Cryopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Which Region Is The Largest In The Stem Cell Cryopreservation Market?

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Stem Cell Cryopreservation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Browse Through More Reports Similar to the Global Stem Cell Cryopreservation Market 2026, By The Business Research Company

Human Embryonic Stem Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cells Therapy Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell And Gene Therapy Manufacturing Services Market

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795